Scandinavlan Life Science venture Company Profile

23:09 EST 14th December 2018 | BioPortfolio

SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. The fund is one of the largest investment funds in Scandinavia in the life science sector with approx. 270 M€ under management.The vision of SLS Venture is to become the leading Scandinavian life science investor with the aim of maximising return on investment by supporting small and mid-sized life science companies with a unique combination of capital, industrial and financial expertise.The management team at SLS Venture has a strong industrial background and an extensive collective experience of research and development, company development and growth of small and large businesses.SLS Venture believes that industrial experience and networks, that we bring to bare, are important when we, as a team, work with investments and are active owners in our portfolio companies. Experience, knowledge and understanding of the business environment surrounding a developing company are necessary and vital. Further, as international experience has shown, a strong local presence is key to success in the venture capital industry. Through our local offices we will not only generate a high quality deal flow but also be able to work closely with the portfolio companies and support them.


Birger Jariagatan 10
SE-114 34


Phone: 46 8 5450 7030
Fax: 46 8 5450 7039

News Articles [2044 Associated News Articles listed on BioPortfolio]

New €270M Life Science Fund Will Have a “Sharp Focus in Biotech”

Venture capitalist firm Forbion has announced the first closing of a new fund that will be investing primarily in European life science companies. Forbion Capital Partners has surpassed its goal of ...

Landets life science-strategi – var med och påverka den!

Det statliga life science-kontorets chef Jennie Nordborg vill veta vad de ska ha med i den nationella life science-strategin. Nu vill hon ha din åsikt!

Kreativ kompetensmatchning – avgörande inom life science

Sedan återhämtningen efter finanskrisen 2008, då många företag världen över drabbades hårt av neddragningar, så har utvecklingen inom life science gått stadigt framåt. Faktum är att life s...

Update: Forbion’s Life Science Fund Tops Goal by €90M

Update: The European venture capital firm Forbion closed fundraising for it’s fourth life sciences fund at €360M, a much greater amount than the anticipated €250M. The oversubscribed fund is...

Athenex and Xiangxue Life create joint venture Axis; Xiangxue grants TCR rights

Athenex Inc. and Xiangxue Life Science (XLS; a division of Guangzhou Xiangxue Pharmaceutical Co. Ltd.) created a 55/45 joint venture, Axis Therapeutics Ltd., to develop TCR-engineered T cells for canc...

California Life Science Sector Workforce Trends Report: Amgen, Pfizer and Genentech Leading Emplo...

The Biocom Institute and California Life Sciences Institute (CLSI) released their third biennial life science industry report. Overall, the report paints a very positive picture of the life science in...

3 Life Science IPOs in August

August brought three life science IPOs split between the New York Stock Exchange and the NASDAQ. Here we review each company for investor consideration. The post 3 Life Science IPOs in August appeared...

5 Life Science IPOs in September

September brought five life science IPOs split between the New York Stock Exchange and the NASDAQ. Here we review each company for investor consideration. The post 5 Life Science IPOs in September app...

PubMed Articles [2183 Associated PubMed Articles listed on BioPortfolio]

A Misguided Venture: Presidential Fitness and the Duty to Warn.

Finding Meaning With Creativity in the Past, Present, and Future.

Being creative is considered a desirable trait, yet most empirical studies emphasize how to increase creativity rather than explore its possible benefits. A natural connection is how creativity can en...

Commentary on "A Misguided Venture: Presidential Fitness and the Duty to Warn".

Dialysis-Facility Joint-Venture Ownership - Hidden Conflicts of Interest.

Colloidal systems chemistry. Replication, reproduction and selection at nanoscale.

Development of synthetic systems carrying life-like features is a long-standing challenge in chemistry and material science. Poor understanding of mechanisms ruling the emergence of life-like features...

Clinical Trials [2346 Associated Clinical Trials listed on BioPortfolio]

Improving STEM Outcomes for Young Children With Language Learning Disabilities

The sophisticated language of science can be a barrier to Science, Technology, Engineering, and Math (STEM) learning, especially for children who have specific language impairment (SLI). T...

Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.

To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 mo...

Next Science Antimicrobial Mouth Rinse Study

To assess the effect of a test antimicrobial oral rinse from Next Science on the prevention of oral biofilm formation and thereby preventing gingivitis by monitoring the oral microbial flo...

Assessment of the Improvement of Wound Healing Rate and Wound Bioburden With the Combination of Next Science Wound Gel and Wash

This is a 12-week, single-site, open-label prospective study in adult with a chronic wound diagnosis. Subjects will be randomized in equal numbers to either the control treatment arm, anti...

Using Focus Groups to Assess the Impact of Environmental Health Science Programs for K-12 Educational Community

The MIDAS Project (Models of Implementation and Dissemination of Environmental Health and Science Across Subjects) Assessment Objectives: - Determine whether students are aware of the ...

Companies [2963 Associated Companies listed on BioPortfolio]

Scandinavlan Life Science venture

SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. The...

Frontline BioVentures

Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life ...

Nextech Venture, L.P

Nextech Venture, L.P., founded in 1999, is a U.S. limited partnership withCHF 70 million under management and with an office in Zurich, Switzerland. We are investing in selected life science companies...

Fountain Healthcare Partners

Fountain Healthcare Partners is a life science venture capital fund with offices in Dublin, and New York. Founded in 2008, Fountain is Ireland’s largest dedicated life scienc...

Venture Valuation Inc.

Venture Valuation was founded in spring 1999 based on research work by the founder and CEO, Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne...

More Information about "Scandinavlan Life Science venture" on BioPortfolio

We have published hundreds of Scandinavlan Life Science venture news stories on BioPortfolio along with dozens of Scandinavlan Life Science venture Clinical Trials and PubMed Articles about Scandinavlan Life Science venture for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Scandinavlan Life Science venture Companies in our database. You can also find out about relevant Scandinavlan Life Science venture Drugs and Medications on this site too.

Quick Search


Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record